Niagen Bioscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-2.7M | $-4.2M | $169.1K | $3.0M |
| FY2012 | $-10.1M | $-10.1M | $24.6K | $2.7M |
| FY2013 | $-3.9M | $-4.0M | $137.3K | $1.3M |
| FY2015 | $-2.6M | $-2.7M | $123.1K | $2.9M |
| FY2016 | $-2.1M | $-4.4M | $525.2K | $1.2M |
| FY2017 | $-9.8M | $-11.0M | $1.2M | $4.6M |
| FY2018 | $-20.9M | $-22.2M | $1.3M | $6.4M |
| FY2019 | $-20.4M | $-21.2M | $743.0K | $7.2M |
| FY2020 | $-10.6M | $-10.6M | — | $6.9M |
| FY2021 | $-24.2M | $-24.2M | — | $6.2M |
| FY2022 | $-15.1M | $-15.1M | — | $5.7M |
| FY2023 | $7.1M | $7.1M | — | $4.8M |
| FY2024 | $12.1M | $12.1M | — | $3.7M |
| FY2025 | $13.5M | $13.5M | — | $6.1M |